Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Open-Angle Glaucoma, Ocular Hypertension
About this trial
This is an interventional treatment trial for Open-Angle Glaucoma focused on measuring Open-Angle Glaucoma (OAG), Ocular Hypertension (OHT), Bimatoprost
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of either Diagnosis of either open angle glaucoma (OAG) (i.e., primary OAG, pseudoexfoliation glaucoma, pigmentary glaucoma) or ocular hypertension requiring intraocular pressure-lowering treatment.
Exclusion Criteria:
- Concurrent or anticipated enrollment in another investigational drug or device study or participation in such a study within 2 months prior to enrolling in this study.
- Previous administration with Bimatoprost SR in the study eye.
Sites / Locations
- Horizon Eye Specialists & Lasik Centers /ID# 235240
- Atlantis Eye Care /ID# 235530
- Lakeside Vision Center /ID# 234970
- Global Research Foundation /ID# 237350
- The Eye Research Foundation /ID# 234521
- Byers Eye Institute Stanford /ID# 235544
- Foothill Eye Institute /ID# 235640
- Connecticut Eye Consultants P.C. /ID# 234981
- Specialty Retina Center /ID# 236045
- Segal Drug Trials, Inc /ID# 235784
- International Research Center /ID# 238050
- Thomas Eye Group PC /ID# 235737
- Indiana University - Glick Eye Institute /ID# 235886
- Midwest Eye Institute /ID# 237876
- Tulane University /ID# 237632
- Ophthalmic Consultants of Boston /ID# 236534
- Clinical Eye Research of Boston LLC /ID# 234966
- University of Michigan, Kellogg Eye Center /ID# 236496
- Fraser Eye Center /ID# 235790
- Silverstein Eye Centers /ID# 237881
- Moyes Eye Center PC /ID# 234989
- Alterman Modi & Wolter /ID# 235248
- The Ohio State University /ID# 236790
- AMA Eyes Research Institute /ID# 235542
- Dean McGee Eye Institute /ID# 236823
- Oklahoma Eye Surgeons /ID# 235849
- Drs Fine Hoffman & Sims LLC /ID# 235918
- Ophthalmic Partners, PC /ID# 235741
- Scott and Christie and Associates /ID# 234593
- Black Hills Regional Eye Institute /ID# 235075
- Vance Thompson Vision /ID# 235072
- Eye Specialty Group /ID# 235721
- Vanderbilt University Medical Center /ID# 237177
- Advancing Vision Research /ID# 236681
- ATX Clinical Trials Inc. dba Keystone Research /ID# 235868
- Medical Center Ophthalmology Associates - Keystone Research /ID# 235787
- Southern Utah Medical Research /ID# 235602
- Piedmont Eye Center /ID# 234534
- Consultorio Oftalmologico Dr. Fabian Lerner /ID# 235855
- Hospital Universitario Austral /ID# 237727
- Oftalmología Global /ID# 239187
- Hospital Italiano /ID# 235851
- Centro Privado de Ojos /ID# 241283
- Centro oftalmologico Dr Charles /ID# 235881
- Oftar Mendoza /ID# 240535
- Eye Surgery Associates /ID# 235873
- Multiprofile Hospital for Active Treatment "Lozenetz" /ID# 244053
- Medical Center Oxycom Burgas /ID# 235580
- UMHAT Sveti Georgi /ID# 237027
- MHAT Hadzhi Dimitar /ID# 238248
- MHAT Dr. Bratan Shukerov /ID# 235498
- Medical center for eye healt Focus Ltd /ID# 235575
- Pentagram Eye Hospital /Id# 235813
- Specialized Hospital for Active Treatment in Ocular Diseases "Zrenie" /ID# 235500
- Diagnostic consultative center Aleksandrovska /ID# 238105
- St. Sofia Hospital /ID# 235525
- Medical Center -Verea /ID# 235494
- Medical center Orfey /ID# 237344
- MHAT Trakia /ID# 238137
- Specialized Ophthalmological Hospital for Active Treatment - Varna /ID# 235962
- Ocni klinika Pardubice /ID# 235944
- Fakultni nemocnice Kralovske Vinohrady /ID# 234323
- Vseobecna fakultni nemocnice v Praze /ID# 234422
- Rigshospitalet Glostrup /ID# 235743
- Universitatsklinikum Freiburg /ID# 238048
- Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 237069
- Klinikum Dresden Friedrichstadt /ID# 235308
- Universitaetsmedizin Goettingen /ID# 237377
- Asklepios Kinik Nord - Heidberg Augenklinik /ID# 235955
- St. Franziskus-Hospital /ID# 237714
- Dietrich-Bonhoeffer-Klinikum /ID# 235262
- Universitaetsmedizin Rostock /ID# 237263
- Augenzentrum Dr Hamacher /ID# 235537
- Bugat Pal Korhaz /ID# 238144
- Markusovszky Egyetemi Oktatokorhaz /ID# 237383
- Budapest Retina Intezet /ID# 235950
- Jahn Ferenc Del-pesti Korhaz es Rendelointezet /ID# 237111
- Royal Victoria Eye and Ear Hospital /ID# 235546
- Institute of Eye Surgery /ID# 235547
- University of Catanzaro /ID# 238066
- Eye Clinic University of Catania /ID# 235573
- Ospedale Ss. Annunziata /ID# 236587
- Fondazione IRCCS Policlinico /ID# 236909
- University of Perugia /ID# 235811
- Fondazione Bietti - Ospedale Britannico /ID# 235495
- Sapienza University of Rome - Polo Pontino /ID# 237451
- Southern Eye Specialists /ID# 236080
- Capital Eye Specialists /ID# 236112
- Wojskowy Instytut Medyczny /ID# 237031
- Optimum Profesorskie Centrum Okulistyki Sp. z o.o. /ID# 237076
- Gabinet Okulistyczny Edward Wylegala /ID# 235946
- Medical Center Julianow /ID# 235961
- Centrum Diagnostyki i Mikrochirurgii Oka - LENS sp. z o.o /ID# 235928
- S. Fyodorov Eye Microsurgery Federal State Institution /ID# 235984
- Pretoria Eye Institute - Private Practice /ID# 235658
- Somerset Eye Specialist Medical & Surgical Centre /ID# 235540
- Norrlands University hospital /ID# 237553
- The Princess Alexandra NHS Trust /ID# 234433
- Oxford University Hospitals NHS Foundation Trust /ID# 237282
- Cambridge University Hospitals NHS Foundation Trust /ID# 238255
- Mid Essex Hospitals NHS Trust /ID# 237776
- East Suffolk and North Essex NHS Foundation Trust /ID# 234657
- Mid-Cheshire Hospitals NHS Trust /ID# 235418
- Liverpool University Hospitals NHS Foundation Trust /ID# 237095
- Liverpool University Hospitals NHS Foundation Trust /ID# 237321
- Central Middlesex Hospital /ID# 236216
- King's College Hospital NHS Foundation Trust /ID# 237275
- York and Scarborough Teaching Hospitals NHS Foundation Trust /ID# 237683
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Bimatoprost SR - Dose A
Bimatoprost SR - Dose B
Study Eye: Participants will receive 1 - 3 Cycles of Bimatoprost SR administrations of Dose A Fellow Eye: The eye that does not receive Bimatoprost SR treatment will receive standard of care or up to one administration of Bimatoprost SR.
Study Eye: Participants received 1-3 Cycles of Bimatoprost SR administrations of Dose B Fellow Eye: The eye that does not receive Bimatoprost SR treatment will receive standard of care or up to one administration of Bimatoprost SR.